LNBio

Scientific Programs

Cancer Biology

Study of various aspects of cancer, focusing on discovering new therapeutic intervention.

Neglected Diseases

Discovery and validation of novel treatments for neglected diseases.

Cardiac Biology and Metabolism

Studies of proteins associated to the cardiac development.

Microorganisms and Plants

Analysis of the biological functions of proteins from pathogenic microorganisms.

Publications

A Redox 2-Cys Mechanism Regulates the Catalytic Activity of Divergent Cyclophilins

Novel allosteric regulation in cyclophilins, a target of the Xanthomonas citri
Identification of novel interaction between ADAM17 and thioredoxin-1

LNBio research suggests a negative ADAM17 regulation by thioredoxin-1 (Trx-1).

Facilities

News & Events

Innovation Core

Drug Discovery and Development

The Center for Drug Discovery and Development follows a model in which the drug is discovered at a research facility and further developed by the industry.

What is the LNBio Innovation Core?

LNBio innovation core aims supporting companies on resolving their biotechnological problems as well as helping scientists on translating discoveries into products.

Education

LNBio´s Educational Program

The LNBio.Educa Project was highlighted in various media vehicles during the last month.Check out these press coverage.

Cancer Biology

Neglected Diseases

Cardiac Biology and Metabolism

Microorganisms and Plants

Publications

A Redox 2-Cys Mechanism Regulates the Catalytic Activity of Divergent Cyclophilins

Identification of novel interaction between ADAM17 and thioredoxin-1

LNBio and RENAMA announce selected proposals

Opportunity: Postdoctoral research fellow

Seminar: How divergent cyclophilins regulate their isomerase activity

Latin American Summit Meeting on Biological Crystallography and Complementary Methods

Drug Discovery and Development

What is the LNBio Innovation Core?

LNBio´s Educational Program